• TRACLEER®[bosentan] - DailyMed

      dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm DESCRIPTION. Bosentan is the first of a new drug class, an endothelin receptor antagonist. TRACLEER® (bosentan) belongs to a class of highly substituted pyrimidine ...
    • Tracleer (Bosentan) Drug Information: Description, User ...

      www.rxlist.com/tracleer-drug.htm Learn about the prescription medication Tracleer (Bosentan), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
    • Bosentan: MedlinePlus Drug Information

      www.nlm.nih.gov/medlineplus/druginfo/meds/a605001.html Bosentan is used to treat pulmonary arterial hypertension (PAH, high blood pressure in the vessels that carry blood to the lungs). Bosentan may improve the ...
    • Pulmonary Hypertension Treatment Bosentan (Tracleer ...

      www.phassociation.org/Patients/Treatment/Bosentan What is bosentan? Bosentan is an oral medication classified as an endothelin receptor antagonist (ERA) which is approved for the treatment of pulmonary arterial ...
    • Bosentan (Professional Patient Advice) - Drugs.com

      www.drugs.com/ppa/bosentan.html Professional guide for Bosentan. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.
    • Bosentan - Side Effects, Dosage, Interactions | Everyday Health

      www.everydayhealth.com/drugs/bosentan Bosentan lowers blood pressure in your lungs, helping your heart pump blood more efficiently. Bosentan is used to treat pulmonary arterial hypertension (PAH).
    • Tracleer REMS

      www.tracleerrems.com Indication. Tracleer is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability and to decrease clinical worsening.